Effects of serotonin (5-HT)1B receptor ligands on amphetamine-seeking behavior in rats

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 813-822

  Miszkiel, Joanna ^a   Przegaliñski, Edmund ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

5 HT1B receptor; Amphetamine self Administration; Rat; Reinstatement of amphetamine seeking behavior

Indexed keywords

5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; 5 PROPOXY 3 (1,2,5,6 TETRAHYDRO 4 PYRIDYL)PYRROLO[3,2 B]PYRIDINE; AMPHETAMINE; COCAINE; LIGAND; SB 216641; SEROTONIN 1B ANTAGONIST; SEROTONIN 1B RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SEEKING BEHAVIOR; DRUG SELF ADMINISTRATION; MALE; MOTIVATION; NONHUMAN; RAT; REINFORCEMENT;

AMPHETAMINE; ANIMALS; BENZAMIDES; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DRUG-SEEKING BEHAVIOR; EXTINCTION, PSYCHOLOGICAL; LIGANDS; MALE; OXADIAZOLES; PYRIDINES; RATS; RECEPTOR, SEROTONIN, 5-HT1B; SELF ADMINISTRATION; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS;

EID: 84886525578     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71062-4     Document Type: Article

References (56)

1. Acosta JI, Boynton FA, Kirschner KF, Neisewander JL: Stimulation of 5-HT1B receptors decreases cocaine- and sucrose-seeking behavior. Pharmacol Biochem Behav, 2005, 80, 297-307.
2. Amara SG, Sonders MS: Neurotransmitter transporters as molecular targets for addictive drugs. Drug Alcohol Depend, 1998, 51, 87-96.
3. Benloucif S, Keegan MJ, Galloway MP: Serotoninfacilitated dopamine release in vivo: pharmacological characterization. J Pharmacol Exp Ther, 1993, 265, 373-377.
4. Bruinvels AT, Palacios JM, Hoyer D: Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain. Naunyn Schmiedebergs Arch Pharmacol, 1993, 347, 569-582.
5. Castanon N, Scearce-Levie K, Lucas JJ, Rocha B, Hen R: Modulation of the effects of cocaine by 5-HT1B receptors: a comparison of knockouts and antagonists. Pharmacol Biochem Behav, 2000, 7, 559-566.
6. Childress AR, Ehrman RN, Robbins SJ, McLelan AT, O'Brien CP: Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res Monogr, 1993, 137, 73-95.
7. Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA, 1988, 85, 5274-5278
8. Filip M: Role of serotonin (5-HT)2 receptors in cocaine self-Administration and seeking behavior in rats. Pharmacol Rep, 2005, 57, 35-46.
9. Filip M, Alenina N, Bader M, Przegaliñski E: Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict Biol, 2010, 15, 227-49.
10. Filip M, Frankowska M, Zaniewska M, Golda A, Przegaliñski E: The serotonergic system and its role in cocaine addiction. Pharmacol Rep, 2005, 57, 685-700.
11. Fink KB, Göthert M: 5-HT Receptor regulation of neurotransmitter release. Pharmacol Rev, 2007, 59, 360-417.
12. Fleckenstein AE, Volz TJ, Riddle EL, Gibb JW, Hanson GR: New insights into the mechanism of action of amphetamines. Annu Rev Pharmacol Toxicol, 2007, 47, 681-698.
13. Fletcher PJ, Korth KM: RU-24969 disrupts d-Amphetamine self-Administration and responding for conditioned reward via stimulation of 5-HT1B receptors. Behav Pharmacol, 1999, 10, 183-193.
14. Gorelick DA, Gardner EL, Xi ZX: Agents in development for the management of cocaine abuse. Drugs, 2004, 64, 1547-1573.
15. Guan XM, McBride WJ: Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull, 1989, 23, 541-547.
16. Hagan JJ, Slade PD, Gaster L, Jeffrey P, Hatcher JP, Middlemiss DN: Stimulation of 5-HT1B receptors causes hypothermia in the guinea pig. Eur J Pharmacol, 1997, 331, 169-174.
17. Hill KP, Sofuoglu M: Biological treatments for amphetamine dependence: recent progress. CNS Drugs, 2007, 21, 851-69.
18. Hjorth S, Tao R: The putative 5-HT1B receptor agonist C-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969. Eur J Pharmacol, 1991, 209, 249-252.
19. Jaffe JH, Cascella NG, Kumor KM, Sherer MA: Cocaine-induced cocaine craving. Psychopharmacology (Berl), 1989, 97, 59-64.
20. Jupp B, Lawrence AJ: New horizons for therapeutics in drug and alcohol abuse. Pharmacol Ther, 2010, 125, 138-68.
21. Kampman KM: The search for medications to treat stimulant dependence. Addict Sci Clin Pract, 2008, 4, 28-35.
22. Koe BK, Nielsen JA, Macor JE, Heym J: Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP-94,253. Drug Dev Res, 1992, 26, 241-250.
23. Kuhar MJ, Ritz MC, Boja JW: The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci, 1991, 14, 299-302.
24. Leccese AP, Lyness WH: The effects of putative 5-hydroxytryptamine receptor active agents on D-Amphetamine self-Administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions. Brain Res, 1984, 303, 153-162.
25. Lee MD, Simansky KJ: CP-94,253: a selective serotonin1B (5-HT1B) agonist that promotes satiety. Psychopharmacology (Berl), 1997, 131, 264-270.
26. Lin D, Parsons LH: Anxiogenic-like effect of serotonin1B receptor stimulation in the rat elevated plusmaze. Pharmacol Biochem Behav, 2002, 71, 581-587.
27. Lyness WH, Friedle NM, Moore KE: Increased selfadministration of d-Amphetamine after destruction of 5- hydroxytryptaminergic neurons. Pharmacol Biochem Behav, 1980, 12, 937-941.
28. Miszkiel J, Adamczyk P, Filip M, Przegaliñski E: The effect of serotonin 5HT1B receptor ligands on amphetamine self-Administration in rats. Eur J Pharmacol, 2012, 677, 111-115.
29. Miszkiel J, Filip M, Przegaliñski E: Role of serotonin (5-HT)1B receptors in psychostimulant addiction. Pharmacol Rep, 2011, 63, 1310-1315.
30. Muller CP, Carey RJ, Huston JP, De Souza Silva MA: Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors. Prog Neurobiol, 2007, 81, 133-178.
31. O'Dell LE, Parsons LH: Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels. J Pharmacol Exp Ther, 2004, 311, 711-719.
32. Papla I, Filip M, Przegaliñski E: Effect of intra-tegmental microinjections of 5-HT1B receptor ligands on the amphetamine-induced locomotor hyperactivity in rats. Pol J Pharmacol, 2002, 54, 351-357.
33. Parsons LH, Koob GF, Weiss F: RU 24969, a 5-HT1B/1A receptor agonist, potentiates cocaine-induced increases in nucleus accumbens dopamine. Synapse, 1999, 32, 132-135.
34. Parsons LH, Weiss F, Koob GF: Serotonin1B receptor stimulation enhances cocaine reinforcement. J Neurosci, 1998, 18, 10078-10089.
35. Pazos A, Palacios JM: Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin- 1 receptors. Brain Res, 1985, 346, 205-230.
36. Pentkowski NS, Acosta JI, Browning JR, Hamilton EC, Neisewander JL: Stimulation of 5-HT1B receptors enhances cocaine reinforcement yet reduces cocaineseeking behavior. Addict Biol, 2009, 14, 419-430.
37. Piechal A, Blecharz-Klin K, Wyszogrodzka E, Kolomañska P, Rok-Bujko P, Krzaoecik P, Kostowski W et al.: Neonatal serotonin (5-HT) depletion does not affect spatial learning and memory in rats. Pharmacol Rep, 2012, 64, 266-274.
38. Price GW, Burton MJ, Collin LJ, Duckworth M, Gaster L, Göthert M, Jones BJ et al.: SB-216641 and BRL-15572 - compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors. Naunyn- Schmiedeberg's Arch Pharmacol, 1997, 356, 321-320.
39. Przegaliñski E, Filip M, Papla I, Siwanowicz J: Effect of serotonin (5-HT)1B receptor ligands on cocaine sensitization in rats. Behav Pharmacol, 2001, 12, 109-116.
40. Przegaliñski E, Golda A, Filip M: Effects of serotonin (5-HT)1B receptor ligands on cocaine-seeking behavior in rats. Pharmacol Rep, 2008, 60, 798-810.
41. Przegaliñski E, Golda A, Frankowska M, Zaniewska M, Filip M: Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-Administration in rats. Eur J Pharmacol, 2007, 559, 165-172.
42. Przegaliñski E, Siwanowicz J, Nowak E, Papla I, Filip M: Role of 5-HT1B receptors in the sensitization to amphetamine in mice. Eur J Pharmacol, 2001, 422, 91-99.
43. Rothman RB, Baumann MH: Monoamine transporters and psychostimulant drugs. Eur J Pharmacol, 2003, 479, 23-40.
44. Sarhan H, Cloez-Tayarani I, Massot O, Fillion MP, Fillion G: 5-HT1B receptors modulate release of [3H]dopamine from rat striatal synaptosomes. Naunyn Schmiedebergs Arch Pharmacol, 1999, 359, 40-47.
45. Sarhan H, Fillon G: Differential sensitivity of 5-HT1B auto and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol, 1999, 360, 382-390.
46. Sari Y: Serotonin1B receptors: from protein to physiological function and behavior. Neurosci Biobehav, 2004, 28, 565-582.
47. Schlicker E, Fink K, Molderings GJ, Price GW, Duckworth M, Gaster L, Middlemiss DN, et al.: Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol, 1997, 356, 321-327.
48. Sharp T, Bramwell SR, Grahame-Smith DG: 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol, 1989, 96, 283-290.
49. Tatarczyñska E, Antkiewicz-Michaluk L, Klodziñska A, Stachowicz K, Chojnacka-Wójcik E: Antidepressant-like effect of the selective 5-HT1B receptor agonist CP 94253: a possible mechanism of action. Eur J Pharmacol, 2005, 516, 46-50.
50. Tatarczyñska E, Klodziñska A, Stachowicz K, Chojnacka-Wójcik E: Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxi- ety and depression. Behav Pharmacol, 2004, 15, 523-534.
51. Tran-Nguyen LT, Baker DA, Grote KA, Solano J, Neisewander JL: Serotonin depletion attenuates cocaine-seeking behavior in rats. Psychopharmacology (Berl), 1999, 146, 60-66.
52. United Nations Office on Drugs and Crime (UNODC), 2010. World Drug Report. Vienna
53. White FJ, Kalivas PW: Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend, 1998, 51, 141-153.
54. Xi ZX, Gardner EL: Hypothesis-driven medication discovery for the treatment of psychostimulant addiction. Curr Drug Abuse Rev, 2008, 1, 303-327.
55. Yan QS, Yan SE: Activation of 5-HT1B/1D receptors in the mesolimbic dopamine system increases dopamine release from the nucleus accumbens: a microdialysis study. Eur J Pharmacol, 2001, 418, 55-64.
56. Yan QS, Zheng SZ, Yan SE: Involvement of 5-HT1B receptors within the ventral tegmental area in regulation of mesolimbic dopaminergic neuronal activity via GABA mechanisms: a study with dual-probe microdialysis. Brain Res, 2004, 1021, 82-91.